KYNTRA BIO, INC. Shareholders' Equity
KYNTRA BIO, INC. (KYNB) had Shareholders' Equity of -$30.14 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent -$30.14M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$43.80M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$30.04M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$17.03M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$30.14M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$43.80M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | -$30.04M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$17.03M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | -$223.00M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | -$216.90M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | -$225.60M 10-K · filed 2026-03-16 | |
| 2024-09-30 | -$243.67M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$232.34M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | -$228.12M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | -$204.17M 10-K · filed 2025-03-17 | |
| 2023-09-30 | -$157.17M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | -$102.27M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | -$48.85M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | -$21.45M 10-K · filed 2024-02-26 | |
| 2022-09-30 | $26.31M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $103.78M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $158.05M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $209.15M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $325.79M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $260.58M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $371.00M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $422.18M 10-K/A · filed 2022-03-04 | |
| 2020-09-30 | $451.66M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $395.87M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $458.36M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $516.13M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $594.45M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $629.03M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $489.22M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $509.20M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $471.31M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $495.53M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $499.52M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $528.47M 10-K · filed 2019-02-27 | $563.18M 10-K · filed 2018-02-27 |
| 2017-09-30 | $571.50M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $230.10M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $131.70M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $155.84M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $178.34M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $193.11M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $156.95M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $177.55M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $217.28M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $253.62M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $184.62M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $221.41M 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |